Prudential Financial
BEAM icon

Prudential Financial’s Beam Therapeutics BEAM Stock Holding History

Prudential Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Buy
16,360
+1,435
+10% +$43.3K ﹤0.01% 1863
2026
Q1 		$356K Buy
+14,925
New +$414K ﹤0.01% 1971
2025
Q4 		– Sell
-11,890
Closed -$289K – 2236
2025
Q3 		$289K Buy
11,890
+45
+0.4% +$895 ﹤0.01% 2105
2025
Q2 		$245K Buy
+11,845
New +$206K ﹤0.01% 2152
2024
Q4 		– Sell
-14,089
Closed -$345K – 2316
2024
Q3 		$345K Buy
+14,089
New +$364K ﹤0.01% 2361
2022
Q2 		– Sell
-3,900
Closed -$224K – 2671
2022
Q1 		$224K Buy
3,900
+25
+0.6% +$1.64K ﹤0.01% 2488
2021
Q4 		$309K Sell
3,875
-325
-8% -$27.8K ﹤0.01% 2392
2021
Q3 		$365K Buy
4,200
+475
+13% +$47.7K ﹤0.01% 2255
2021
Q2 		$479K Buy
3,725
+420
+13% +$33.5K ﹤0.01% 2154
2021
Q1 		$265K Buy
3,305
+300
+10% +$28.5K ﹤0.01% 2315
2020
Q4 		$245K Buy
+3,005
New +$148K ﹤0.01% 2306

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Prudential Financial's BEAM Position: Q2 2026 in Review

Prudential Financial increased its Beam Therapeutics (BEAM) stake by 9.6% in Q2 2026, buying an estimated $43.3K and bringing the position to 16,360 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

Prudential Financial first reported a position in BEAM in Q4 2020 and has held it in 11 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Prudential Financial held 16,360 shares of Beam Therapeutics worth $561K as of Q2 2026.
  • Prudential Financial bought 1,435 Beam Therapeutics shares in Q2 2026, an estimated $43.3K.
  • Beam Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1863 holding.
  • Prudential Financial first reported a position in Beam Therapeutics in Q4 2020 and has held it in 11 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.